Literature DB >> 6616623

Does the higher order structure of the influenza virus ribonucleoprotein guide sequence rearrangements in influenza viral RNA?

P A Jennings, J T Finch, G Winter, J S Robertson.   

Abstract

Subgenomic RNAs (sgRNAs) were isolated from defective interfering virus produced by high multiplicity passage of the human influenza strain A/PR/8/34. Cloning and sequencing of 35 unique sgRNAs revealed that many were about 400 nucleotides long, containing about 200 nucleotides from each of the 5' and 3' ends of a full-length segment. Most of the sgRNAs were derived from segment 1, but there were examples from six other segments, including those encoding the haemagglutinin and neuraminidase. Our analysis of the sequence rearrangements found in sgRNAs indicates that they may be generated from the standard viral segments by a jumping viral polymerase that makes transitions between adjacent regions of the RNA template in the ribonucleoprotein tertiary structure.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6616623     DOI: 10.1016/0092-8674(83)90394-x

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  88 in total

1.  Identification of amino acid residues of influenza virus nucleoprotein essential for RNA binding.

Authors:  D Elton; L Medcalf; K Bishop; D Harrison; P Digard
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

2.  Hairpin loop structure in the 3' arm of the influenza A virus virion RNA promoter is required for endonuclease activity.

Authors:  M B Leahy; H C Dobbyn; G G Brownlee
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

3.  A single amino acid mutation in the PA subunit of the influenza virus RNA polymerase promotes the generation of defective interfering RNAs.

Authors:  Ervin Fodor; Louise J Mingay; Mandy Crow; Tao Deng; George G Brownlee
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

4.  3D structure of the influenza virus polymerase complex: localization of subunit domains.

Authors:  Estela Area; Jaime Martín-Benito; Pablo Gastaminza; Eva Torreira; José M Valpuesta; José L Carrascosa; Juan Ortín
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-22       Impact factor: 11.205

5.  E339...R416 salt bridge of nucleoprotein as a feasible target for influenza virus inhibitors.

Authors:  Yu-Fang Shen; Yu-Hou Chen; Shao-Ying Chu; Meng-I Lin; Hua-Ting Hsu; Pei-Yu Wu; Chao-Jung Wu; Hui-Wen Liu; Fu-Yang Lin; Gialih Lin; Pang-Hung Hsu; An-Suei Yang; Yih-Shyun E Cheng; Ying-Ta Wu; Chi-Huey Wong; Ming-Daw Tsai
Journal:  Proc Natl Acad Sci U S A       Date:  2011-09-19       Impact factor: 11.205

6.  In vivo analysis of the promoter structure of the influenza virus RNA genome using a transfection system with an engineered RNA.

Authors:  K Yamanaka; N Ogasawara; H Yoshikawa; A Ishihama; K Nagata
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-15       Impact factor: 11.205

7.  Ultrastructural and functional analyses of recombinant influenza virus ribonucleoproteins suggest dimerization of nucleoprotein during virus amplification.

Authors:  J Ortega; J Martín-Benito; T Zürcher; J M Valpuesta; J L Carrascosa; J Ortín
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

8.  Hierarchy among viral RNA (vRNA) segments in their role in vRNA incorporation into influenza A virions.

Authors:  Yukiko Muramoto; Ayato Takada; Ken Fujii; Takeshi Noda; Kiyoko Iwatsuki-Horimoto; Shinji Watanabe; Taisuke Horimoto; Hiroshi Kida; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

9.  Mutational analysis of cis-acting RNA signals in segment 7 of influenza A virus.

Authors:  Edward C Hutchinson; Martin D Curran; Eliot K Read; Julia R Gog; Paul Digard
Journal:  J Virol       Date:  2008-09-24       Impact factor: 5.103

10.  Studies of defective interfering RNAs of Sindbis virus with and without tRNAAsp sequences at their 5' termini.

Authors:  M Tsiang; S S Monroe; S Schlesinger
Journal:  J Virol       Date:  1985-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.